Saikadatu, Halil .
HRN: 26-86-89 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/04/2025
04/10/2025
IV
50mg
Q24
PROM
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes